Form 8-K - Current report:
SEC Accession No. 0001140361-22-027187
Filing Date
2022-07-28
Accepted
2022-07-28 06:02:27
Documents
12
Period of Report
2022-07-22
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10040095_8k.htm   iXBRL 8-K 21181
  Complete submission text file 0001140361-22-027187.txt   155743

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ions-20220722.xsd EX-101.SCH 3874
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20220722_lab.xml EX-101.LAB 22546
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20220722_pre.xml EX-101.PRE 16050
6 EXTRACTED XBRL INSTANCE DOCUMENT brhc10040095_8k_htm.xml XML 4056
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 221112604
SIC: 2834 Pharmaceutical Preparations